{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System",
        "BD Phoenix\u2122 Automated Microbiology System Vancomycin (0.5-32 \u00b5g/mL) GP-Detection of VRSA"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K060493",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K020323",
        "K020322",
        "K030677"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "March 29, 2006",
    "Summary Letter Received Date": "February 24, 2006",
    "Submission Date": "February 22, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Vancomycin"
    ],
    "Specimen Type(s)": [
        "Pure culture of aerobic Gram-negative bacteria",
        "Pure culture of facultative anaerobic Gram-negative bacteria",
        "Pure culture of Gram-positive bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth based microdilution",
        "Redox indicator detection",
        "Automated susceptibility testing"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Minimal inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "Automated system",
        "Analyzer",
        "Panel",
        "Software",
        "Broth",
        "Indicator solution",
        "Tray"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System for vancomycin antimicrobial susceptibility testing of Gram-positive and Gram-negative bacteria, including detection of vancomycin resistant Staphylococcus aureus (VRSA).",
    "Indications for Use Summary": "Intended for rapid identification and in vitro antimicrobial susceptibility testing of isolates from pure culture of most aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria of human origin, specifically including quantitative determination of vancomycin susceptibility and detection of vancomycin resistant Staphylococcus aureus.",
    "fda_folder": "Microbiology"
}